CIMP+ cells, unlike CIMP- cell lines, typically demonstrate cancer-specific methylation of key regulatory genes (mainly DNA mismatch repair and tumor suppressors) and exhibit abnormal DNMT activity [34–37]. This evidence concerns the gene DNMT1 and cancer.